摘要
目的观察强心化瘀方对慢性心力衰竭的临床疗效。方法将106例慢性心力衰竭患者随机分为治疗组(A组,应用强心化瘀方治疗,69例)和对照组(B组,应用西医综合治疗,37例),比较两组总有效率、心功能改善状况、心力衰竭常见症状及体征改善率。结果 A组总有效率高于B组(94.20%vs.72.98%)(P<0.05)。治疗后,A组气短、心悸、疲劳乏力、咳嗽咳痰和紫绀的改善率均高于B组(91.30%vs.72.97%、81.03%vs.48.28%、65.57%vs.15.63%、77.14%vs.33.33%和75.56%vs.24.13%)(P<0.05)。治疗后,A组心功能Ⅰ级患者所占比例多于B组(P<0.05)。结论强心化瘀方治疗慢性心力衰竭疗效确切,较常规西药疗效好。
Objective To observe the clinical efficacy of Chinese prescription with cardiotonic and stasis-free effects（CP） in treating patients with chronic heart failure （CHF） .Methods A total of 106 patients with CHF was divided into two groups of A （treated with CP ,69 cases） and B（treated with conventional western medicine ,37 cases） .The total effectiveness rate and improvements of heart function were compared between two groups .Results The total clinical effectiveness rate was significantly higher in group A than that in group B （94.20% vs .72.98% ） （ P〈0 .05 ） .The improvement rates of short of breath ,palpitation ,fatigue ,cough and expectoration ,and cyanosis after treatment were significantly higher in group A than those in group B （91.30% vs .72.97% ,81 .03%vs .48.28% ,65.57% vs .15.63% ,77.14% vs .33.33% and 75.56% vs .24.13% ）（P〈0 .05） .The percentage of patients with cardiac function grade Ⅰ was more in group A than that in group B （P〈0 .05） .Conclusion The CP is more effective than conventional western medicine in the treatment of CHF .
出处
《江苏医药》
CAS
2015年第8期933-935,共3页
Jiangsu Medical Journal
关键词
强心化瘀方
慢性心力衰竭
Chinese prescription with cardiotonic and stasis-free effects
Chronic heart
